Teledentistry has emerged as a promising tool in bridging the gap in healthcare accessibility, particularly in regions like Latin America region, where resources for oral healthcare are often limited. Drawing upon a comprehensive review of literature, this overview assessed the applications and clinical outcomes of teledentistry in diagnosing oral potentially malignant disorders (OPMDs) and oral cancer, highlighting the challenges and opportunities specific to the Latin American context. Moreover, it examined the integration of artificial intelligence algorithms and teledentistry for enhancing diagnostic accuracy, thereby optimizing resource allocation and improving patient outcomes. By elucidating the current landscape and future prospects, this overview provided insights for policymakers, healthcare providers, and researchers, fostering advancements in oral healthcare delivery with the aim of reducing the burden of OPMDs and oral cancer in the Latin American region.

Geographic areas like Argentine Patagonia face significant barriers in the fight against oral cancer due to great distances, extreme weather conditions, and a shortage of specialists. These factors contribute to delayed diagnosis and treatment, adversely affecting patient outcomes. The aim of this study was to describe a pilot project to establish the telemedicine network of Chubut (Argentine Patagonia) for the early diagnosis of oral cancer. This perspective study also aimed to describe the advantages and disadvantages of using this tool in remote areas with limited access to healthcare services. Healthcare professionals, including nurses, dentists, doctors, and healthcare workers, were trained in the early diagnosis of oral cancer and high-risk oral lesions by five specialists in Oral Medicine, who traveled throughout Argentine Patagonia. Additionally, training was provided on the use of smartphones to obtain clinical images and data for remote consultations via telemedicine with a specialized center. Over 2,000 km were traveled, and more than 100 healthcare professionals were trained in six towns and localities in Patagonia, Argentina, encountering various limitations for the use of telemedicine in remote areas, such as connectivity issues. The first telemedicine network of Patagonia for the diagnosis of oral cancer was created and is now operational, receiving teleconsultations and referrals from the professionals trained during the journey. This study highlighted that telemedicine is an important tool to overcome geographical barriers and improve access to medical care, especially in remote areas. It promotes agility and speed in referrals and optimizes the available resources of the health system. Future studies should analyze the impact of telemedicine in decreasing the delay of oral cancer diagnosis in Southern Argentina.

In the United Kingdom (UK), the current prevalence rates of oropharyngeal cancer linked to human papillomavirus (HPV) are 6.29% and 2.04% in men and women, respectively. Over the years, the burden of this disease has increased in the UK, and this is mainly due to the rising prevalence of HPV infection in the UK. Research evidence has shown that over 70% of oropharyngeal cancers in the UK are linked to HPV. Oral sex is the major route of transmission of HPV, and over 63% of UK young adults are found to have a positive history of oral sex practice. However, only a minority of the UK population are aware of HPV-associated oropharyngeal cancer; this therefore calls for more public health efforts to increase awareness and knowledge on HPV-associated oropharyngeal cancer in the UK. While the use of technology-based, clinic-based, and community-based interventions have been employed to improve public awareness and knowledge on the role of HPV-associated oropharyngeal cancer, mobile health (mhealth) interventions have not been seriously explored despite existing robust evidence on the effective roles of mhealth in improving awareness and knowledge in diverse diseases. This article therefore calls for the adoption and use of mhealth interventions in educating the UK’s population on HPV-associated oropharyngeal cancer. The use of mhealth interventions in this regard is highly viable as its implementation closely aligns with the country’s National Health Service (NHS) commitment towards the digital transformation of the UK’s healthcare system.